NFE2L2 and chronic obstructive pulmonary disease: In cells harvested from COPD patients and in related in vivo models, the pharmacological up-regulation of Nrf2 enhances the anti-infectious response against the most frequent bacterial pathogens but to date these effects have not been confirmed in intact humans.